Millennium Management
PDLI

Millennium Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Millennium Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-45,861
Closed -$144 – 5875
2020
Q3 		$144 Sell
45,861
-113,158
-71% -$361K ﹤0.01% 4155
2020
Q2 		$463K Buy
159,019
+145,120
+1,044% +$459K ﹤0.01% 3449
2020
Q1 		$39K Sell
13,899
-676,972
-98% -$2.18M ﹤0.01% 3688
2019
Q4 		$2.24M Buy
690,871
+442,251
+178% +$1.28M ﹤0.01% 2549
2019
Q3 		$537K Sell
248,620
-175,432
-41% -$469K ﹤0.01% 3207
2019
Q2 		$1.33M Buy
424,052
+355,364
+517% +$1.15M ﹤0.01% 2633
2019
Q1 		$256K Sell
68,688
-225,154
-77% -$760K ﹤0.01% 3636
2018
Q4 		$852K Buy
293,842
+92,697
+46% +$255K ﹤0.01% 2668
2018
Q3 		$529K Buy
201,145
+182,768
+995% +$449K ﹤0.01% 3224
2018
Q2 		$43K Sell
18,377
-238,164
-93% -$665K ﹤0.01% 3712
2018
Q1 		$754K Sell
256,541
-1,321,065
-84% -$3.61M ﹤0.01% 2839
2017
Q4 		$4.32M Sell
1,577,606
-1,942,992
-55% -$5.97M 0.01% 1810
2017
Q3 		$11.9M Buy
3,520,598
+3,074,010
+688% +$8.55M 0.02% 1135
2017
Q2 		$1.1M Buy
446,588
+331,527
+288% +$763K ﹤0.01% 2400
2017
Q1 		$261K Sell
115,061
-524,109
-82% -$1.16M ﹤0.01% 3106
2016
Q4 		$1.35M Buy
639,170
+378,581
+145% +$1.06M ﹤0.01% 2082
2016
Q3 		$873K Sell
260,589
-333,189
-56% -$1.06M ﹤0.01% 2338
2016
Q2 		$1.86M Sell
593,778
-1,100,609
-65% -$3.67M ﹤0.01% 1824
2016
Q1 		$5.64M Sell
1,694,387
-741,385
-30% -$2.31M 0.01% 1177
2015
Q4 		$8.62M Buy
2,435,772
+1,883,196
+341% +$7.88M 0.02% 1008
2015
Q3 		$2.78M Sell
552,576
-344,039
-38% -$1.97M 0.01% 1699
2015
Q2 		$5.76M Sell
896,615
-377,831
-30% -$2.53M 0.01% 1309
2015
Q1 		$8.97M Buy
1,274,446
+1,001,340
+367% +$7.25M 0.02% 1077
2014
Q4 		$2.11M Buy
273,106
+109,133
+67% +$864K ﹤0.01% 1937
2014
Q3 		$1.23M Buy
+163,973
New +$1.52M ﹤0.01% 2175
2014
Q2 		– Sell
-51,600
Closed -$429K – 4295
2014
Q1 		$429K Sell
51,600
-29,900
-37% -$256K ﹤0.01% 2714
2013
Q4 		$688K Buy
81,500
+52,959
+186% +$446K ﹤0.01% 2517
2013
Q3 		$227K Sell
28,541
-63,684
-69% -$512K ﹤0.01% 3032
2013
Q2 		$712K Buy
+92,225
New +$719K ﹤0.01% 2145

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Millennium Management's PDLI Position: Q4 2020 in Review

Millennium Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 45,861 shares — an estimated $144 sold.

Millennium Management first reported a position in PDLI in Q2 2013 and held it in 29 quarters. The position peaked at $11.9M in Q3 2017. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Millennium Management reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Millennium Management sold 45,861 PDL BioPharma, Inc. shares in Q4 2020, an estimated $144.
  • Millennium Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 29 quarters.
  • Millennium Management's PDL BioPharma, Inc. position peaked at $11.9M in Q3 2017.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.